The effects of the components of the renin-angiotensin system on the isolated perfused human placental cotyledon

D. G. Glance, M. G. Elder, D. L. Bloxam, L. Myatt

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Angiotensins I, II, and III, renin substrate, and des-Asp1-angiotensin I were injected as a bolus into either the maternal or fetal circulation of human placental cotyledons perfused in vitro. All drugs tested produced dose-related increments in fetal perfusion pressure when injected into the fetal circulation, with the order of potency being angiotensin I ≈ angiotensin II ≈ angiotensin III ≳ des-Asp1-angiotensin I ≳ renin substrate. The responses to all the drugs could be blocked by the competitive inhibitor of angiotensin II, (Sar1, Ala8)-angiotensin II, but only the actions of angiotensin I, renin substrate, and des-Asp1-angiotensin I could be blocked by angiotensin converting enzyme inhibitor. When the agents were injected into the maternal circulation, only angiotensins II and III caused dose-related increments in fetal perfusion pressure. Possibly, the placenta may be the main site of conversion of angiotensin I to angiotensin II in the fetoplacental unit, and angiotensin II produced by the placenta could act locally to control fetoplacental blood flow.

Original languageEnglish (US)
Pages (from-to)450-454
Number of pages5
JournalAmerican Journal of Obstetrics and Gynecology
Volume149
Issue number4
DOIs
StatePublished - Jun 15 1984
Externally publishedYes

Fingerprint

Cotyledon
Renin-Angiotensin System
Angiotensin II
Angiotensin I
Angiotensin III
Placenta
Perfusion
Mothers
Placental Circulation
Pressure
Angiotensin-Converting Enzyme Inhibitors
Pharmaceutical Preparations
des-angiotensin I renin substrate

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

The effects of the components of the renin-angiotensin system on the isolated perfused human placental cotyledon. / Glance, D. G.; Elder, M. G.; Bloxam, D. L.; Myatt, L.

In: American Journal of Obstetrics and Gynecology, Vol. 149, No. 4, 15.06.1984, p. 450-454.

Research output: Contribution to journalArticle

@article{16d990073c1e4cbc856b7cd39396a106,
title = "The effects of the components of the renin-angiotensin system on the isolated perfused human placental cotyledon",
abstract = "Angiotensins I, II, and III, renin substrate, and des-Asp1-angiotensin I were injected as a bolus into either the maternal or fetal circulation of human placental cotyledons perfused in vitro. All drugs tested produced dose-related increments in fetal perfusion pressure when injected into the fetal circulation, with the order of potency being angiotensin I ≈ angiotensin II ≈ angiotensin III ≳ des-Asp1-angiotensin I ≳ renin substrate. The responses to all the drugs could be blocked by the competitive inhibitor of angiotensin II, (Sar1, Ala8)-angiotensin II, but only the actions of angiotensin I, renin substrate, and des-Asp1-angiotensin I could be blocked by angiotensin converting enzyme inhibitor. When the agents were injected into the maternal circulation, only angiotensins II and III caused dose-related increments in fetal perfusion pressure. Possibly, the placenta may be the main site of conversion of angiotensin I to angiotensin II in the fetoplacental unit, and angiotensin II produced by the placenta could act locally to control fetoplacental blood flow.",
author = "Glance, {D. G.} and Elder, {M. G.} and Bloxam, {D. L.} and L. Myatt",
year = "1984",
month = "6",
day = "15",
doi = "10.1016/0002-9378(84)90161-3",
language = "English (US)",
volume = "149",
pages = "450--454",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - The effects of the components of the renin-angiotensin system on the isolated perfused human placental cotyledon

AU - Glance, D. G.

AU - Elder, M. G.

AU - Bloxam, D. L.

AU - Myatt, L.

PY - 1984/6/15

Y1 - 1984/6/15

N2 - Angiotensins I, II, and III, renin substrate, and des-Asp1-angiotensin I were injected as a bolus into either the maternal or fetal circulation of human placental cotyledons perfused in vitro. All drugs tested produced dose-related increments in fetal perfusion pressure when injected into the fetal circulation, with the order of potency being angiotensin I ≈ angiotensin II ≈ angiotensin III ≳ des-Asp1-angiotensin I ≳ renin substrate. The responses to all the drugs could be blocked by the competitive inhibitor of angiotensin II, (Sar1, Ala8)-angiotensin II, but only the actions of angiotensin I, renin substrate, and des-Asp1-angiotensin I could be blocked by angiotensin converting enzyme inhibitor. When the agents were injected into the maternal circulation, only angiotensins II and III caused dose-related increments in fetal perfusion pressure. Possibly, the placenta may be the main site of conversion of angiotensin I to angiotensin II in the fetoplacental unit, and angiotensin II produced by the placenta could act locally to control fetoplacental blood flow.

AB - Angiotensins I, II, and III, renin substrate, and des-Asp1-angiotensin I were injected as a bolus into either the maternal or fetal circulation of human placental cotyledons perfused in vitro. All drugs tested produced dose-related increments in fetal perfusion pressure when injected into the fetal circulation, with the order of potency being angiotensin I ≈ angiotensin II ≈ angiotensin III ≳ des-Asp1-angiotensin I ≳ renin substrate. The responses to all the drugs could be blocked by the competitive inhibitor of angiotensin II, (Sar1, Ala8)-angiotensin II, but only the actions of angiotensin I, renin substrate, and des-Asp1-angiotensin I could be blocked by angiotensin converting enzyme inhibitor. When the agents were injected into the maternal circulation, only angiotensins II and III caused dose-related increments in fetal perfusion pressure. Possibly, the placenta may be the main site of conversion of angiotensin I to angiotensin II in the fetoplacental unit, and angiotensin II produced by the placenta could act locally to control fetoplacental blood flow.

UR - http://www.scopus.com/inward/record.url?scp=0021276426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021276426&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(84)90161-3

DO - 10.1016/0002-9378(84)90161-3

M3 - Article

VL - 149

SP - 450

EP - 454

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4

ER -